Regulatory authorities do not approve it for human or veterinary use
Looking more closely at the balance between efficacy and safety for each drug, while considering dosing titration strategies, we compare safety based on adverse event (AE) rates, AE-related discontinuation rates, and rates of nausea and vomiting
GLP-1RAs improve risk factors for CV disease, including weight loss, blood glucose control, blood pressure reduction, and lipid improvement
GLP-1 drugs work by mimicking the hormone and keeping it around longer, which can aid in appetite suppression
Boesen has been involved with amicus, or friend of the court, briefs in lawsuits brought by Novo Nordisk and Eli Lilly over GLP-1 compounding, and is currently representing a med spa in a GLP-1-related case brought by Eli Lilly earlier this month